Hamandi and colleagues reviewed outcomes for 95 patients who underwent isolated tricuspid valve (TV) surgery between 2007 and 2017 at their institution. For 41% of patients, the procedure was reoperative, following either prior coronary artery bypass grafting or prior valve surgery. Valve repair was performed in over 70% of patients.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Tricuspid
June 4, 2019
This video demonstrates a novel totally endoscopic redo isolated tricuspid repair approach that requires minimal dissection.
May 24, 2019
Patient Care and General Interest
Despite being the leading cause of death in the US, heart disease was the most-Googled disease in only one state: Maine.
May 14, 2019
Abdelhadi Ismail of the Southampton University Hospitals Trust in the UK presents an educational series on cardiac anatomy in which he discusses some of the fundamental concepts.
April 20, 2019
The American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), American Society of Echocardiography (ASE), Society for Cardiovascular Angiography and Interventions (SCAI), and Society of Thoracic Surgeons (STS) published a joint expert consensus and evidence-based recommendations for systems of care related to valvular he
April 11, 2019
The Heart Valve Society Annual Meeting 2019 streamed live from Sitges, Spain. Find the plenary sessions here.
March 31, 2019
In this state-of-the-art review review, the authors summarize current knowledge of anatomic, structural, metabolic, functional, and hemodynamic characteristics of the right ventricle (RV) in both health and disease. Highlights of this review are:
February 8, 2019
Patient Care and General Interest
November 13, 2018
This video demonstrates a tricuspid annuloplasty. The authors detail the procedure in a step-by-step fashion, using diagrams and surgical video to illustrate key technical elements.
September 25, 2018
This multicenter study evaluated the efficacy of medical therapy plus transcatheter valve repair (MitraClip) to medical therapy alone for heart failure accompanied by secondary moderate to severe mitral regurgitation. The device group experienced significantly fewer hospitalizations and lower mortality at 24 months follow-up.